Aimmune Therapeutics Inc AIMT:NASDAQ

Last Price$16.51Cboe Real-Time Last Sale as of 12:12PM ET 4/09/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.65(4.10%)
Bid (Size)$16.45 (200)
Ask (Size)$16.47 (100)
Day Low / High$16.10 - 16.87
Volume640.9 K

Sector Update: Health Care Sprinting Forward in Wednesday Afternoon Trading

1:59PM ET 2/05/2020 MT Newswires
Top Health Care Stocks

JNJ +1.27%

PFE +1.74%

ABT +1.22%

MRK -3.04%

AMGN +5.50%

Health care stocks were sharply higher, with the NYSE Health Care Index rising 1.5% in recent trade while the shares of health care companies in the S&P 500 also were up almost 2.2% as a group. The Nasdaq Biotechnology index also was climbing 3.6%.

Among health care stocks moving on news:

(+) Cerner (CERN) rose more than 6% after the health care information technology company reported non-GAAP Q4 net income of $0.75 per share, improving on a $0.63 per share adjusted profit during the same quarter last year and beating the Capital IQ consensus by $0.01 per share. Revenue rose to $1.44 billion from $1.37 billion a year ago, topping the $1.43 billion Street view.

In other sector news:

(+) Aimmune Therapeutics (AIMT) climbed 5.6% on Wednesday after saying Nestle Health Science was making an additional $200 million equity investment in the biopharmaceuticals company, boosting its total investment to $473 million.

(-) Gilead Sciences (GILD) fell 1.5% after the specialty drugmaker reported below-consensus Q4 net income, earning $1.30 per share during the three months ended Dec. 31 and falling short of the $1.67 per share profit expected, on average, by analysts. Gilead shares also were facing resistance after the US patent office Wednesday said it's unlikely the company will win cases challenging the government ownership of the patents underlying HIV drugs.

Price: 78.83, Change: +4.61, Percent Change: +6.21